5-Azacytidine depletes HSCs and synergizes with an anti-CD117 antibody to augment donor engraftment in immunocompetent mice. Read more about 5-Azacytidine depletes HSCs and synergizes with an anti-CD117 antibody to augment donor engraftment in immunocompetent mice.
American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation. Read more about American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation.
Nf1 and Sh2b3 mutations cooperate in vivo in a mouse model of juvenile myelomonocytic leukemia. Read more about Nf1 and Sh2b3 mutations cooperate in vivo in a mouse model of juvenile myelomonocytic leukemia.
Macrophage activation syndrome-like manifestations (MAS-L) following BCMA-directed CAR T-cells in multiple myeloma Read more about Macrophage activation syndrome-like manifestations (MAS-L) following BCMA-directed CAR T-cells in multiple myeloma
IFN-γ signature in the plasma proteome distinguishes pediatric hemophagocytic lymphohistiocytosis from sepsis and SIRS. Read more about IFN-γ signature in the plasma proteome distinguishes pediatric hemophagocytic lymphohistiocytosis from sepsis and SIRS.
Infectious complications in relapsed refractory multiple myeloma patients after BCMA CAR T therapy Read more about Infectious complications in relapsed refractory multiple myeloma patients after BCMA CAR T therapy
FcεRIγ-negative NK cells persist in vivo and enhance efficacy of therapeutic monoclonal antibodies in multiple myeloma. Read more about FcεRIγ-negative NK cells persist in vivo and enhance efficacy of therapeutic monoclonal antibodies in multiple myeloma.
Genomic and clinical characterization of early T-cell precursor lymphoblastic lymphoma. Read more about Genomic and clinical characterization of early T-cell precursor lymphoblastic lymphoma.
Transplant-associated thrombotic microangiopathy in pediatric patients: pre-HSCT risk stratification and prophylaxis. Read more about Transplant-associated thrombotic microangiopathy in pediatric patients: pre-HSCT risk stratification and prophylaxis.
Single-cell DNA sequencing reveals complex mechanisms of resistance to quizartinib. Read more about Single-cell DNA sequencing reveals complex mechanisms of resistance to quizartinib.
